美宝湿润烧伤膏在防预乳腺癌改良根治术后放射性皮肤损伤的护理效果观察

Nursing Effect of MEBO on Preventing Radiation Skin Injury after Modified Radical Mastectomy for Breast Cancer

目的:观察美宝湿润烧伤膏在防御乳腺癌改良根治术后放射性皮肤损伤的护理效果。方法:随机抽取我院于2016年11月至2018年4月期间收治的30例乳腺癌改良根治术后需行放射治疗的患者作为本次研究样本,按住院编号奇数、偶数将其均分为参照组(15例)、研究组(15例)。给予参照组常规护理,研究组在参照组的常规护理的基础上给予美宝湿润烧伤膏治疗,观察比较两组患者的各级皮肤损伤发生率、治疗前期急性放射性皮炎的发生率及安全性情况。结果:参照组的各级皮肤损伤发生率分别为0.00%、20.00%、53.33%、26.67%、0.00%;研究组的各级皮肤损伤发生率分别为0.00%、53.33%、26.67%、20.00%、0.00%,参照组Ⅱ级、Ⅲ级皮肤损伤发生率明显高于研究组,研究组的I级皮肤损伤发生率明显高于参照组,但组间比较无明显差异,P>0.05;而参照组在治疗前期急性放射性皮炎的发生率73.33%(11例),研究组在治疗前期急性放射性皮炎的发生率33.33%(5例),研究组的治疗前期急性放射性皮炎的发生率明显低于参照组,存在统计学意义(P<0.05);同时未发现参照组与研究组出现不良反应情况发生,表示美宝湿润烧伤膏的安全性好。结论:美宝湿润烧伤膏在防御乳腺癌改良根治术后放射性皮肤损伤中具有显著效果,可减少患者在治疗前期急性放射性皮炎的发生率,缓解皮肤损伤的情况,且安全性佳,无不良反应情况发生,对临床护理研究具有参考意义。

Objective: To observe the nursing effect of MEBO in preventing radiation skin injury after modified radical mastectomy. Methods: Thirty patients undergoing radiotherapy after modified radical mastectomy in our hospital from November 2016 to April 2018 were randomly selected as the study samples. According to the odd number and even number of the patients, they were divided into the control group(15 cases)and study group(15 cases). Routine nursing was given to the reference group, and the study group was treated with MEBO on the basis of routine nursing in the reference group. The incidence of skin injury at all levels, incidence and safety of projectile dermatitis were observed and compared between the two groups.Results: The incidence of skin injury at all levels in the reference group was 0.00%、20.00%、53.33%、26.67%、0.00%, respectively. The incidence of skin injury in the study group was 0.00%、53.33%、26.67%、20.00%、0.00%,respectively. The incidence of skin injury in the reference group was significantly higher than that in the study group in II grade and III grade. The incidence of grade I skin injury in the study group was significantly higher than that in the control group, but there was no significant difference between the two groups(P> 0.05). The occurrence of acute radiation dermatitis in the control group before treatment was 73.33%(11 cases). The incidence of acute radiation dermatitis in the study group was 33.33%(5 cases). The incidence of acute radiation dermatitis in the study group was significantly lower than that in the control group(P<0.05). At the same time,no adverse reactions occurred in the reference group and the study group, indicating that MEBO was safe. Conclusion: MEBO has a significant effect in preventing radiation skin injury after modified radical mastectomy, which can reduce the incidence of acute radiation dermatitis and relieve skin injury in patients with breast cancer before treatment. The occurrence of adverse reactions has reference significance for clinical nursing research.